FindTrial
Sign In

Analgesic effect of ropivacaine combined with dexamethasone on quadratus lumborum block in laparoscopic nephrectomy

Analgesic effect of ropivacaine combined with dexamethasone on quadratus lumborum block in laparoscopic nephrectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900020733
Enrollment
Unknown
Registered
2019-01-15
Start date
2019-02-01
Completion date
Unknown
Last updated
2019-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

renal tumor

Interventions

control group:No block
ropivacaine group:QLB with 0.375% ropivacaine 0.4ml/kg
ropivacaine combined with dexamethasone:QLB with 0.375% ropivacaine 0.4 ml/kg and dexamethasone 10 mg

Sponsors

Fujian Provincial Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA I-II, aged 18-65 years; 2. Elective laparoscopic partial or total renal resection.

Exclusion criteria

Exclusion criteria: Allergic to local anesthetics, inability to comprehend visual analogue scale (VAS) pain scoring system or use patient controlled analgesia (PCA) pump, severe cardiopulmonary disfunction,coagulopathy abnormalities, puncture site infection and body mass index (BMI) was greater than 32 kg/m2 or less than 18 kg/m2 and chronic opioid dependence and long-term use of various types of analgesics.

Design outcomes

Primary

MeasureTime frame
perioperative opioid consumption;—

Secondary

MeasureTime frame
visual analogue pain scale;sensory block level;PONV incidence;remedial analgesia;first time to use PCA;—

Countries

China

Contacts

Public ContactYu Zenggui

Provincial clinical medical college, Fujian Medical University

2271910206@qq.com+86 13509379453

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026